Department of Nano-Bio Convergence
- Head of Division
Park, Seong-gyu
Department Introduction
Department of Nano-Bio Convergence is focusing our all efforts to create innovative technical solutions for nanobiosensor and environmental industries. Current main research activities cover development of 3D nanoplasmonic sensor substrates, novel bioassay techniques using highly sensitive 3D nanochips, and low-temperature plasma and functional nanomaterials for inactivation of airborne pathogens.
Major Activities
- Development of nano·bio sensing materials and applications: 17 papers published, 4 patents registered, 5 patents applied
- Development of pathogen removal materials in indoor air of public facilities: 3 papers published, 4 domestic and foreign patents applied, 4 technology transfers
- Development of Antibacterial/antiviral materials: 1 patent applied, press publicity
Major Research Area
- Development of plasmonic nano·bio sensing materials and on-site disease diagnostic platform
- Clinical evaluation of on-site disease diagnostic system
- Antibacterial/antiviral materials for coating on filter fiber for air cleaner and mask
- Low-temperature plasma applications for airborne pathogen elimination filter
- Development of a material that gives antibacterial/antiviral properties without changing the physical properties of various products that are commonly used
Future Research Plan
- Development of highly sensitive and reproducible plasmonic biosensors
- Commercialization of plasma-applied pathogen removal materials and devices.
- Development of molecular bonding technology between dissimilar materials using ion beam surface treatment technology
- Commercialization of the technology by promoting the establishment of a research institute spin-off company
Major R&D Activities
Development of on-site and wearable narcotic drug detection sensor
- Development of highly sensitive and wearable plasmonic nanomaterials with SERS EF of 1 x 108
- Development of protein film materials for selective narcotic drug collection
- Development of on-site and wearable sensor prototype as a field-applicable system that detects molecules in human sweat within 1 min
Development of antibacterial/antiviral technology that can sterilize and inactivate pathogens in air to respond to infectious diseases that cause secondary infections such as tuberculosis and COVID-19
- Development of a new concept Dielectric Filter Discharge parts with excellent pressure loss, power consumption, and ozone emission characteristics to inactivate pathegens.
- Development of a roll-to-roll technology for non-damaged/high adhesion antiviral materials coating on filter used in masks and air purifier using ion beam technology
- Verification of more than 99% of COVID-19 inactivated.